Literature DB >> 29779671

Resting-State Connectivity Biomarkers of Cognitive Performance and Social Function in Individuals With Schizophrenia Spectrum Disorder and Healthy Control Subjects.

Joseph D Viviano1, Robert W Buchanan2, Navona Calarco1, James M Gold2, George Foussias3, Nikhil Bhagwat4, Laura Stefanik1, Colin Hawco5, Pamela DeRosse6, Miklos Argyelan6, Jessica Turner7, Sofia Chavez8, Peter Kochunov2, Peter Kingsley6, Xiangzhi Zhou6, Anil K Malhotra6, Aristotle N Voineskos9.   

Abstract

BACKGROUND: Deficits in neurocognition and social cognition are drivers of reduced functioning in schizophrenia spectrum disorders, with potentially shared neurobiological underpinnings. Many studies have sought to identify brain-based biomarkers of these clinical variables using a priori dichotomies (e.g., good vs. poor cognition, deficit vs. nondeficit syndrome).
METHODS: We evaluated a fully data-driven approach to do the same by building and validating a brain connectivity-based biomarker of social cognitive and neurocognitive performance in a sample using resting-state and task-based functional magnetic resonance imaging (n = 74 healthy control participants, n = 114 persons with schizophrenia spectrum disorder, 188 total). We used canonical correlation analysis followed by clustering to identify a functional connectivity signature of normal and poor social cognitive and neurocognitive performance.
RESULTS: Persons with poor social cognitive and neurocognitive performance were differentiated from those with normal performance by greater resting-state connectivity in the mirror neuron and mentalizing systems. We validated our findings by showing that poor performers also scored lower on functional outcome measures not included in the original analysis and by demonstrating neuroanatomical differences between the normal and poorly performing groups. We used a support vector machine classifier to demonstrate that functional connectivity alone is enough to distinguish normal and poorly performing participants, and we replicated our findings in an independent sample (n = 75).
CONCLUSIONS: A brief functional magnetic resonance imaging scan may ultimately be useful in future studies aimed at characterizing long-term illness trajectories and treatments that target specific brain circuitry in those with impaired cognition and function.
Copyright © 2018 Society of Biological Psychiatry. All rights reserved.

Entities:  

Keywords:  Biomarker; Functional outcomes; Imaging; Machine learning; Resting-state fMRI; Schizophrenia

Mesh:

Substances:

Year:  2018        PMID: 29779671      PMCID: PMC6177285          DOI: 10.1016/j.biopsych.2018.03.013

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  74 in total

Review 1.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

Review 2.  The mirror neuron system and the consequences of its dysfunction.

Authors:  Marco Iacoboni; Mirella Dapretto
Journal:  Nat Rev Neurosci       Date:  2006-11-08       Impact factor: 34.870

Review 3.  The functional significance of social cognition in schizophrenia: a review.

Authors:  Shannon M Couture; David L Penn; David L Roberts
Journal:  Schizophr Bull       Date:  2006-08-17       Impact factor: 9.306

4.  Theory of mind in schizophrenia: exploring neural mechanisms of belief attribution.

Authors:  Junghee Lee; Javier Quintana; Poorang Nori; Michael F Green
Journal:  Soc Neurosci       Date:  2011       Impact factor: 2.083

Review 5.  Molecular pathology of schizophrenia: more than one disease process?

Authors:  T J Crow
Journal:  Br Med J       Date:  1980-01-12

6.  Empirical validation of primary negative symptoms: independence from effects of medication and psychosis.

Authors:  M E Kelley; D P van Kammen; D N Allen
Journal:  Am J Psychiatry       Date:  1999-03       Impact factor: 18.112

7.  Altered functional and anatomical connectivity in schizophrenia.

Authors:  Jazmin Camchong; Angus W MacDonald; Christopher Bell; Bryon A Mueller; Kelvin O Lim
Journal:  Schizophr Bull       Date:  2009-11-17       Impact factor: 9.306

8.  A novel DTI-QA tool: Automated metric extraction exploiting the sphericity of an agar filled phantom.

Authors:  Sofia Chavez; Joseph Viviano; Mojdeh Zamyadi; Peter B Kingsley; Peter Kochunov; Stephen Strother; Aristotle Voineskos
Journal:  Magn Reson Imaging       Date:  2017-10-17       Impact factor: 2.546

Review 9.  FSL.

Authors:  Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

10.  White matter alterations in deficit schizophrenia.

Authors:  Laura M Rowland; Elena A Spieker; Alan Francis; Peter B Barker; William T Carpenter; Robert W Buchanan
Journal:  Neuropsychopharmacology       Date:  2008-12-03       Impact factor: 7.853

View more
  22 in total

1.  A longitudinal multi-scanner multimodal human neuroimaging dataset.

Authors:  Colin Hawco; Erin W Dickie; Gabrielle Herman; Jessica A Turner; Miklos Argyelan; Anil K Malhotra; Robert W Buchanan; Aristotle N Voineskos
Journal:  Sci Data       Date:  2022-06-14       Impact factor: 8.501

Review 2.  Recent advancements in biomarker research in schizophrenia: mapping the road from bench to bedside.

Authors:  Shivangi Patel; Dilip Sharma; Ankit Uniyal; Anagha Gadepalli; Vinod Tiwari
Journal:  Metab Brain Dis       Date:  2022-03-03       Impact factor: 3.655

Review 3.  Approaches to Defining Common and Dissociable Neurobiological Deficits Associated With Psychopathology in Youth.

Authors:  Antonia N Kaczkurkin; Tyler M Moore; Aristeidis Sotiras; Cedric Huchuan Xia; Russell T Shinohara; Theodore D Satterthwaite
Journal:  Biol Psychiatry       Date:  2019-12-23       Impact factor: 13.382

4.  Social Cognitive Networks and Social Cognitive Performance Across Individuals With Schizophrenia Spectrum Disorders and Healthy Control Participants.

Authors:  Lindsay D Oliver; Colin Hawco; Philipp Homan; Junghee Lee; Michael F Green; James M Gold; Pamela DeRosse; Miklos Argyelan; Anil K Malhotra; Robert W Buchanan; Aristotle N Voineskos
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-12-05

5.  Aberrant triple-network connectivity patterns discriminate biotypes of first-episode medication-naive schizophrenia in two large independent cohorts.

Authors:  Sugai Liang; Qiang Wang; Andrew J Greenshaw; Xiaojing Li; Wei Deng; Hongyan Ren; Chengcheng Zhang; Hua Yu; Wei Wei; Yamin Zhang; Mingli Li; Liansheng Zhao; Xiangdong Du; Yajing Meng; Xiaohong Ma; Chao-Gan Yan; Tao Li
Journal:  Neuropsychopharmacology       Date:  2021-01-06       Impact factor: 8.294

6.  A technical review of canonical correlation analysis for neuroscience applications.

Authors:  Xiaowei Zhuang; Zhengshi Yang; Dietmar Cordes
Journal:  Hum Brain Mapp       Date:  2020-06-27       Impact factor: 5.038

Review 7.  The Core Deficit of Classical Schizophrenia: Implications for Predicting the Functional Outcome of Psychotic Illness and Developing Effective Treatments.

Authors:  Peter F Liddle
Journal:  Can J Psychiatry       Date:  2019-08-21       Impact factor: 4.356

Review 8.  Neuroimaging Heterogeneity in Psychosis: Neurobiological Underpinnings and Opportunities for Prognostic and Therapeutic Innovation.

Authors:  Aristotle N Voineskos; Grace R Jacobs; Stephanie H Ameis
Journal:  Biol Psychiatry       Date:  2019-09-17       Impact factor: 13.382

9.  Viewing ambiguous social interactions increases functional connectivity between frontal and temporal nodes of the social brain.

Authors:  Matthew Ainsworth; Jérôme Sallet; Olivier Joly; Diana Kyriazis; Nikolaus Kriegeskorte; John Duncan; Urs Schüffelgen; Matthew Fs Rushworth; Andrew H Bell
Journal:  J Neurosci       Date:  2021-06-04       Impact factor: 6.167

Review 10.  Studying and modulating schizophrenia-associated dysfunctions of oligodendrocytes with patient-specific cell systems.

Authors:  Florian J Raabe; Sabrina Galinski; Sergi Papiol; Peter G Falkai; Andrea Schmitt; Moritz J Rossner
Journal:  NPJ Schizophr       Date:  2018-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.